Hypertension Diagnostics, Inc. (HDII)

USD 0.0

(0.0%)

Market Cap (In USD)

13.68 Thousand

Revenue (In USD)

-

Net Income (In USD)

-

Avg. Volume

14.65 Thousand

Currency
USD
Country
Financial Services
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-4-0.0016
PE
-
EPS
-
Beta Value
-53.227
ISIN
US44914V1044
CUSIP
44914V104
CIK
1058828
Shares
136814000.0
Earnings Annoncement
-

Company Profile

Sector
Financial Services
Industry
Shell Companies
CEO
Liangjian Peng
Employee Count
-
Website
https://www.hypertensiondiagnostics.com
Ipo Date
1998-08-07
Details
Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.

More Stocks